The link between TAMs, ECM remodelling in cancer [146], and TG2 is currently under-explored, and given the growing evidence that TAM/CAF-mediated remodelling appears critical to the exclusion of anti-cancer immune responses [147], further work in this field would be informative. This evidence concerns the gene TGM2 and cancer.